Only mismatch repair (MMR)-deficient colorectal cancer (CRC) appears to respond well to programmed death (PD)-1 inhibition at the present time. Emerging evidence suggests a role for micro-environmental factors such as CD25 1 cells modulating response to PD-1 inhibition. 
Introduction
Systemic therapy has led to some improvement in survival for patients with advanced colorectal cancer (CRC) during the past few decades; however, it remains a major cause of cancer-related mortality in the western world [1] . Therapeutic reversal of programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) pathway-mediated cancer immune suppression has emerged recently as a potent therapeutic target in some forms of cancer, but has not been effective for the majority of metastatic CRC except for those with mismatch repair (MMR) deficiency [2] . This observation is surprising, as there are relatively similar levels of PD-L1 expression between MMR-proficient and -deficient cancers [3] . A lower mutational burden resulting in reduced neoepitopes in MMR-proficient cancer has been hypothesized as one factor explaining reduced responsiveness to antagonism of immunosuppression [2] . However, emerging evidence suggests that tumour immune alterations beyond PD-L1 expression may also modulate responsiveness to PDL-1/PD-1 pathway antagonism. A recent study reported significantly enhanced response to PD-1 inhibition following depletion of CD25 1 cells [4] .
Cyclooxygenase-2 (Cox-2) over-expression is associated ubiquitously with intestinal adenomas of familial adenomatous polyposis (FAP) [5] and more than 70% of sporadic colorectal adenomas [6] . However, up to half of MMR-deficient CRC may not over-express Cox-2 [7] , while lower levels of Cox-2 over-expression have been reported for the others [8] . In contrast to most other mammalian tissues where Cox-2 is an inducible gene, Cox-2 is expressed constitutively by intestinal lamina propria mononuclear cells (LPMNCs), where it has been shown to play a role in the establishment of dietary immune tolerance [9] . The observation that prostaglandin E 2 (PGE 2 ) can induce regulatory phenotype in CD4 1 T lymphocytes (T regs ) [10] has suggested a mechanism for Cox-2 in immune suppression. We have shown previously that intestinal LPMNC Cox-2-dependent PGE 2 production increases in C57BL/6 mice after the age of weaning ($ 4 weeks of age), with further up-regulation of intestinal LPMNC Cox-2-dependent PGE 2 production in the Apc Min/1 model of FAP during the phase of appearance of macroscopic adenomas [11] . Our study and others [11] [12] [13] have suggested that macrophages, fibroblasts and vascular endothelial cells are the predominant source of intestinal Cox-2 expression in Apc mutant mice. Furthermore, CD4-T reg adoptive transfer led paradoxically to intestinal adenoma regression and reduced Cox-2 expression in the Apc Min/1 model [14] . Conversely, adoptive transfer of naive CD4 1 T lymphocytes had the opposite effect of promoting intestinal tumorigenesis in the Apc Min/1 mouse in association with inflammatory mononuclear infiltrates [15] . This has suggested a potential interaction between T regs and mononuclear phagocytes in the intestinal micro-environment to modulate intestinal tumorigenesis.
To yield insight into the role of Cox-2 expression in intestinal immune changes, we compared intestinal regulatory CD4-lymphocyte populations between Apc Min/1 , Cox-2 inhibitor-treated Apc Min/1 and wild-type mice. We also studied T reg association with Cox-2 expressing cells.
Materials and methods

Animals
All animal work was carried out with appropriate UK Home Office and local ethical committee approval.
Apc
Min/1 and Apc 1/1 (wild-type) mice on the C57BL/6 background obtained from the Jackson Laboratory (Bar Harbor, ME, USA) were bred according to UK Home Office guidelines under specific pathogen-free conditions at the University of Edinburgh and had free access to water and a standard RM1 diet (DBM, Livingston, UK). Some Apc Min/1 mice were fed an RM1 TM diet containing 300 parts per million (p.p.m.) of Celecoxib (Pfizer, Madison, NJ, USA) from weaning (approximately 4 weeks of age) until analysis.
Adenoma counts and intestinal epithelial or LPMNC isolation
Mice were killed by a schedule 1 method (cervical dislocation). Intestinal adenomas were counted macroscopically by O.O.F., blinded to mouse diet. After removing visible Peyer's patches, intestinal LPMNCs were isolated as described previously [9] . LPMNC viability was assessed by trypan blue exclusion. Viability generally ranged between 75 and 85%. Intestinal epithelial cells obtained during the ethylenediamine tetraacetic acid (EDTA) (Invitrogen, Paisley, UK) incubation phase of LPMNC isolation were lysed in TRIZOL TM (Invitrogen) and stored at 2208C for realtime polymerase chain reaction (PCR) analysis. LPMNCs obtained after enzymatic digestion of residual intestinal tissue were washed in phosphate-buffered saline (PBS) containing 5% fetal calf serum (FCS) (Sigma, Poole, UK) and used for flow cytometric analysis.
Tissue processing
Mice at $ 4 (range 5 4-5) or 15 (range 5 14-16) weeks of age were culled and small intestine dissected out from the pylorus to the ileo-caecal junction. Intestinal lumina were flushed out with PBS until no luminal content was evident. The intestinal tissue was then opened longitudinally, segments fixed in methacarn (60% methanol, 30% chloroform and 10% glacial acetic acid) were dehydrated in ethanol and embedded in wax; 5-lm sections were obtained from wax-embedded tissue.
Immunohistochemistry (IHC)
Forkhead box protein 3 (FoxP3). Anti-FoxP3 antibody (e-Bioscience, Hatfield, UK) and anti-CD3 antibody (Dako, Ely, UK) IHC staining was carried out on methacarn fixed tissue as described [14] . Antigen retrieval was by means of Borg decloaker (Biocare Medical, Pacheco, CA, USA). FoxP3 staining was visualized with diaminobenzidine (DAB) from Dako and CD3 with Vector blue (Vector Labs, Peterborough, UK). The number of positive cells for either of these markers was determined by counting from 10 alternate villi in distal small intestine. Anti-transforming growth factor (TGF)-b antibody (R&D Systems, Abingdon, UK) IHC was carried out as described previously and developed with DAB [16] . Single-stained sections were counterstained with Mayer's haematoxylin.
Dual immunohistochemistry
Cox-2. Methacarn-fixed intestinal sections were stained with 10 mg/ml of affinity-purified rabbit anti-mouse Cox-2 antibody (160126; Cayman Chemicals, Ann Arbor, MI, USA) overnight at 48C. Controls included Cox-2 antibody mixed with 310 its concentration of its competing peptide (360106; Cayman Chemicals). An anti-rabbit secondary antibody was used, with development of staining with DAB [17] . Sections were then washed in PBS and underwent FoxP3 immunohistochemistry as described above, except that staining was developed with alkaline phosphatase rather than DAB. Real-time PCR analysis. RNA was isolated from cells lysed in TRIZOL as advised by the manufacturer. Subsequently, cDNA was generated using a reverse transcription kit (Invitrogen). Genomic contamination was excluded using intron spanning primers to Cox-1 (forward: CAC AGT GCG GTC CAA CCT TAT, reverse: GAT GTA GTC ATG CGC TGA GTT GT) and looking for genomic-DNA sized PCR products on 2% agarose gels. Otherwise, real-time PCR was carried out with the following primers: Hprt (forward: TGA AAG ACT TGC TCG AGA TGT CA, reverse-CAC ACA GAG GGC CAC AAT GT); Tgf-b1 (forward: GCA GTG GCT GAA CCA AGG A, reverse: AGC AGT GAG CGC TGA ATC G); and Tslp (forward: CCC TGG CTG CCC TTC ACT, reverse CAT TGA GGG CTT CTC TTG TTC TC). All PCR primers were obtained from Invitrogen. PCR was then carried out on an Applied Biosystems 7700 machine using SYBR-green TM dye for fluorescence detection. PCR conditions were an annealing temperature of 608C for 30s, then amplification for 60 s at 728C for 40 cycles followed by 728C for 10 min. The level of expression of Tgf-b1 (Tgf-b) or Tslp was normalized to the housekeeping gene Hprt.
Flow cytometry
Statistics. Group data are summarized and presented as the mean value 6 standard error of the mean. Data were analysed by Mann-Whitney using Prism TM software. Differences were considered statistically significant at a P-value of < 0Á05.
Results
Increased numbers of FoxP3
1 small intestinal T lymphocytes in Apc Min/1 compared with wild-type mice
We compared T reg (FoxP3-expressing cell) numbers between Apc Min/1 (n53) and wild-type (n 5 3) mouse small intestine at 15 weeks of age. CD3 (as a pan-T lymphocyte marker) was used to control for the total number of T lymphocytes. Double IHC showed that all FoxP3 1 cells were also CD3 1 (Fig. 1b) . and wild-type mice (Fig. 1b) . However, FoxP3 1 cells were also localized to the interstitium of intestinal adenomas in Apc Min/1 mice, particularly in a subepithelial location (shown later in Fig. 3 ). The number of FoxP3 1 cells per villus in Apc Min/1 mouse small intestine was more than double the number observed in wild-type littermates, despite no significant difference in the number of CD3 1 cells (Fig. 1d,e) (Fig. 2f,g ). The CD4 
An increased CD25
1 regulatory T lymphocyte population during tumorigenesis in Apc Min/1 mouse intestine IL-2 receptor-alpha (CD25) is a low-affinity IL-2 receptor expressed by T regs and activated lymphocytes [19] . We therefore analysed FoxP3 and CD25 expression by LP CD4 lymphocytes of Apc Min/1 and wild-type mice to determine the phenotype of the increased T reg population occurring during the phase of increased Cox-2 expression (Fig. 2h,i) .
As observed previously, a significantly increased CD4 (Fig. 2i ).
Cox-2-inhibitor therapy inhibits small intestinal tumorigenesis and prevents the increase in CD4 We determined initially if Cox-2 inhibitor therapy (with Celecoxib 300 parts ppm) prevented intestinal tumorigenesis in Apc Min/1 mice, as described previously [16] . Figure   3a shows that Celecoxib treatment led to an 85% reduction in intestinal adenoma numbers in Apc Min/1 mice. We then determined the effect of Cox-2 inhibition on the T reg population of 15-week-old Apc Min/1 mice.
Celecoxib therapy had no significant effect on the CD25 mice (24Á56 6 0Á59%; n 5 4) and those fed a control diet (24Á12 6 2Á18%; n 5 8) (P 5 0Á933). This suggested that even though Cox-2 inhibition decreased the CD25 1 intestinal T reg population, it did not decrease the total intestinal T reg population. 3 ) was similar to the distribution of Cox-2 1 cells in our previous study [11] and those of others [12] . Therefore, to substantiate the possibility of paracrine interaction between T regs and Cox-2 expressing mononuclear phagocytes, we carried out co-immunohistochemistry for FoxP3 and Cox-2 expression on intestinal adenomas of Apc Min/1 mice.
FoxP3 and Cox-2 expressing cells were co-localized to the interstitium of intestinal adenomas (Fig. 3g) . Helios expression has been reported to stabilize T reg function [21] . We further characterized the increased intestinal T regs occurring after the phase of increased Cox-2-dependent PGE 2 production in Apc Min/1 mice (Fig. 4) .
We compared Helios expression by LP T regs of 15-weekold Apc Min/1 and wild-type mice (Fig. 4) . Among CD4 Tslp and Tgf-b expression by small intestinal epithelial cells of Apc Min/1 and wild-type mice at different ages
We then compared known molecular signals to T reg generation between Apc Min/1 and wild-type mice. We compared small intestinal epithelial Tgf-b [22] and Tslp [23] mRNA expression prior to and after the period of increased Cox-2 dependent PGE 2 production. Increased Tgf-b mRNA expression was observed between 4 and 15 weeks of age in Apc Min/1 and wild-type mice (Fig. 5a ), but levels of Tgf-b mRNA expression were similar between Apc Min/1 and wildtype mice at either age tested. In contrast, we observed a trend towards decreased small intestinal epithelial Tslp mRNA expression between 4 and 15 weeks of age in Apc Min/1 and wild-type mice, but no difference in levels of
Tslp mRNA expression between Apc Min/1 and wild-type mice at either age tested (Fig. 5b) .
Discussion
To the best of our knowledge, this is the first description of an association between Cox-2 activity and T reg of age compared to younger mice (Mann-Whitney U-test). Tslp expression was more variable in the younger age group; although the results did not achieve significance, there was a trend for higher Tslp expression in younger animals of both genotypes.
phenotypical variation during intestinal tumorigenesis in the Apc Min/1 model. We show an increased predominantly CD4
1 Apc Min/1 small intestinal T reg population with age during the phase of adenoma development. This is consistent with previous reports of increased T regs in the tumor micro-environment [24] . Similarly, we previously showed induction of human T regs in vitro by a small-cell lung cancer cell line [25] . Perhaps the most important finding was a Cox-2-dependent increased CD25
1 intestinal T reg population which is Helios
1
. We also demonstrate co-localization of T regs and Cox-2 expressing mononuclear phagocytes. Taken together, these suggest that paracrine interaction between Cox-2 expressing mononuclear phagocytes and T regs in Apc Min/1 mouse intestine modulate the T reg phenotype.
Determining the functional significance of phenotypical observations reported here, as well as the relationship between Cox-2 and PD-1/PDL-1 expression, were beyond the scope of this study. However, diphtheria-toxinmediated FoxP3-expressing cell depletion in the Apc Min/1 mouse has been reported to increase intestinal T lymphocyte infiltrates with a proinflammatory stroma as a consequence [26] . Nevertheless, the functional significance of the CD25
1 FoxP3 1 subpopulation in the intestinal immune microenvironment is not known. The recent observation that antibody-mediated depletion of CD25 1 cells in a mouse model enhanced response to PD-1 antagonism suggests their potential in-vivo relevance. CD25-null mice (IL-2Ra-null) had reduced sensitivity to IL-2, which compromised T lymphocyte function associated with polyclonal expansion of T lymphocytes [27] . With respect to T regs , it is known that IL-2R-STAT-5-mediated signalling generates activated STAT-5, which is essential for stabilization of FoxP3 expression by binding the conserved noncoding sequence 2 (CNS2) region of the FoxP3 promoter [28] . Additionally, the Ikaros transcription factor Helios is known to have STAT-5b as one of its principal targets in mice, stabilizing STAT-5-dependent IL-2 responsiveness [21] . The observation that constitutive STAT-5b activation increased intestinal adenoma size in the Apc Min/1 mouse is consistent with a role for IL-2R--STAT-5 T reg activation in promoting intestinal tumorigenesis [29] . It is noteworthy that constitutive STAT-5b activation abrogated proinflammatory cytokine secretion while modifying expression of cell surface molecules by T lymphocytes [29] . These, taken together, suggest that abrogation of an increased intestinal CD25
1 T reg population during tumorigenesis in ApcMin/ 1 mice by Cox-2 inhibition could impair T reg function, thus countering tumour immunosuppression. Our observation that the CD25 1 T reg population of unconnected lymph nodes is not increased during tumorigenesis and unaffected by Cox-2 inhibition suggests selectivity of the LP T reg phenotypical modification as a potential therapeutic target, compared to non-specific ablation of the CD25 With regard to underlying mechanisms, the observation of an increased proportion of CD25 -LP T regs and increased intestinal epithelial Tgf-b expression with age in wild-type mice would be consistent with the generation of adaptive T regs by TGF-b activity in intestinal immune tolerance [30] . However, there was no increase in levels of Tgf-b expression in Apc Min/1 compared with wild-type small intestine to explain the further increase in the number of CD25 -T regs observed with the inhibition of Cox-2 activity. The observation that Cox-2 inhibition is known to suppress the growth of adenomas greater than 1 mm in size, but does not abrogate adenoma growth completely, may explain this [31] . Consequently, one explanation for increased CD25 -T regs in Apc Min/1 with Cox-2 inhibition could be increased TGF-b derived from an increased number of intestinal epithelial cells within adenomas, rather than increased levels of Tgf-b expression in Apc Min/1 mice. However, an alternative tumour-specific signal to LP T reg generation during the process of tumorigenesis (which was not the purpose of this study) cannot be excluded. With reference to our observations, it has been proposed that, in different circumstances, TGF-b can generate T regs via diverse molecular pathways [dependent upon or independent of CD25 signalling] [32] . Furthermore, a previous study showed conversion of CD25 -T regs to CD25 1 T regs by TGF-b to mediate immunosuppression in tumours [33] .
Of possible relevance to this is the fact that TGF-b has been shown to induce alternative activation of mononuclear phagocytes [34] . Our study suggests that Cox-2 inhibition reverses paracrine effects of alternately activated macrophages to enhance CD25 expression in T regs of the Apc 
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